AEON AEON Biopharma Inc Com

Previous Close
52 Week Low
52 Week High
Market Cap $0
Shares 21,996,103
Float 10,155,958
Enterprise Value $0
Volume 0
Av. Daily Volume 0
Stock charts supplied by TradingView

Upcoming Catalysts

Drug Stage Catalyst Date
ABP-450 (prabotulinumtoxinA)
Cervical dystonia
Phase 2
Phase 2
Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 14-day FREE TRIAL.
ABP-450 (prabotulinumtoxinA)
Migraine (prophylaxis)
Phase 2
Phase 2
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien.

Drug Pipeline

Drug Stage Notes
ABP-450 (prabotulinumtoxinA)
Phase 1
Phase 1
IND expected late 2021. Phase 2a clinical study to initiate 2022.